Kyorin Eye Center
Mitaka, Tokyo, 181-8611, Japan
NCT Number: NCT02628158
Fundus autofluorescence (FAF) at the macula originates from hyperfluorescence from retinal pigment epithelium (RPE) and blockage of hyperfluorescence by macular pigment. Investigators evaluate whether presence of FAF may correlate to the postoperative visual outcome for epiretinal membrane.
Looking for future studies?
Notify Me20 year–90 year
Observational
Mitaka, Tokyo, 181-8611, Japan
92 eyes with epiretinal membrane were performed vitreous surgery, epiretinal membrane removal and internal limiting membrane (ILM) peeling. Presence of hyperfluorescence in FAF at the macular area and best-corrected visual acuity (BCVA) was evaluated preoperatively and at postoperative 1, 3, and 6 months with ultra-wide angle imaging.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Vitrectomy with removal of epiretinal membrane and internal limiting membrane
Time frame: Changes from baseline to 1, 3, 6 months
Vision
Time frame: Changes from baseline up to 6 months
Fundus autofluorescence
Kyorin University
Other
Correlation of Postoperative Vision and Fundus Autofluorescence After Vitrectomy for Epiretinal Membrane
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07736690
Epiretinal Membrane, Eye Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT04132401
Age-Related Macular Degeneration, Cardiovascular Diseases
Manresa, Barcelona, Spain
View Trial DetailsNCT06459284
Epiretinal Membrane, Eye Diseases
Vienna, Austria
View Trial DetailsNCT06753539
Epiretinal Membrane, Eye Diseases
Vienna, Austria
View Trial Details